StockData
Allarity Therapeutics, Inc. logo

Allarity Therapeutics, Inc. (ALLR) stock

ALLRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.88−0.08 (-8.24%)

Close on Nov 16, 2026Market cap $13.93MP/E –Yield –

Allarity Therapeutics ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Allarity Therapeutics's ebitda for the twelve months ending Jun 30, 2025 was -$26.77M. For fiscal 2024 it was -$27.23M. The highest annual figure on record is -$8.27M in fiscal 2020.

Annual ebitda

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$27.23M–
FY2023Dec 31, 2023-$17.09M–
FY2022Dec 31, 2022-$34.40M–
FY2021Dec 31, 2021-$26.45M–
FY2020Dec 31, 2020-$8.27M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2025Jun 30, 2025-$4.12M–
Q1 FY2025Mar 31, 2025-$3.03M–
Q4 FY2024Dec 31, 2024-$7.32M–
Q3 FY2024Sep 30, 2024-$12.31M–
Q2 FY2024Jun 30, 2024-$3.37M–
Q1 FY2024Mar 31, 2024-$4.24M–
Q4 FY2023Dec 31, 2023-$4.87M–
Q3 FY2023Sep 30, 2023-$4.42M–
Q4 FY2022Dec 31, 2022-$6.75M–
Q3 FY2022Sep 30, 2022-$4.55M–
Q2 FY2022Jun 30, 2022-$4.82M–
Q1 FY2022Mar 31, 2022-$18.29M–
Q4 FY2021Dec 31, 2021-$15.73M–
Q3 FY2021Sep 30, 2021-$3.94M–
Q2 FY2021Jun 30, 2021-$4.38M–
Q1 FY2021Mar 31, 2021-$2.41M–
Q4 FY2020Dec 31, 2020-$2.59M–

More Allarity Therapeutics figures

See a number that looks wrong?